Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Kenneth Ellenbogen Added: 1 year ago
A new policy statement released by HRS underscores the importance of continual training and education for electrophysiologists performing catheter ablation of atrial fibrillation (AF).In this short interview, Dr Kenneth Ellenbogen (VCU School of Medicine, US) discusses the key recommendations within this policy statement to ensure a strong electrophysiology base and skillset to achieve the best… View more
Author(s): Atul Verma Added: 6 months ago
AHA Scientific Sessions 2025 - Dr Atul Verma (McGill University Health Centre, Montreal, CA) joins us to share outcomes from OCEAN (NCT02168829). The prospective, open-label, randomised trial aimed to investigate ongoing oral anticoagulation with rivaroxaban 15 mg daily compared to antiplatelet therapy in patients with clinical stroke risk factors at least one year post-successful catheter… View more
Author(s): Vivek Reddy Added: 2 years ago
EHRA 24 - We interview Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, US) on a first-in-human clinical trial of a novel conformable "single-shot" pulsed field ablation (PFA) catheter for pulmonary vein isolation (PVI).This single arm trial aimed to assess the safety and efficacy of PVI using an 8Fr PFA catheter (SpherePVI, Affera Inc) in 30 patients across three centers.Interview… View more
Author(s): Tina Baykaner , Added: 3 months ago
AF Symposium 2026 - Pulsed field ablation in atrial fibrillation: Will it Redefine AF Ablation Strategies?Arrhythmia Academy board member Dr Tina Baykaner (Stanford University, Stanford, CA, US) is joined by Dr Melanie Gunawardene (CCB Frankfurt und Main-Taunus, Frankfurt, DE) exploring whether pulsed field ablation will fundamentally transform atrial fibrillation ablation strategies in 2026.This… View more
Author(s): Boris Schmidt , Atul Verma Added: 3 months ago
AF Symposium 2026 - Repeat ablation strategies: Moving Beyond Pulmonary Vein Isolation and the Role of Advanced Mapping.Dr Boris Schmidt (Cardioangiologisches Centrum Bethanien, Frankfurt, DE) and Dr Atul Verma (McGill University Health Centre & McGill University, Montreal, CA, US) discuss optimal approaches to redo atrial fibrillation ablation and the critical decision of when to extend beyond… View more
Author(s): Vivek Reddy Added: 3 months ago
Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, New York, NY, US) joins us to discuss evolving strategies for stroke management following atrial fibrillation ablation, addressing the critical question of when anticoagulation can be safely discontinued after successful ablation.Interview Questions:There's been a lot of talk about optimal anticoagulation – what's the headline? In which… View more
Author(s): Frédéric Sacher Added: 1 year ago
EHRA 2025 - Positive safety results of the Affera mapping and ablation system for the treatment of ventricular arrhythmias (VA) show a 6% rate of major complication.Dr Frédéric Sacher (IHU Liryc, Bordeaux, FR) joins us on-site at EHRA Congress 2025 to discuss safety results from the European Affera Ventricular Arrhythmia Ablation Registry, investigating VA ablation with the Affera Sphere-9… View more